SeromYx Systems Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
SeromYx Systems, Inc. operates in the biotechnology research sector, focusing on high-throughput antibody characterization and Systems Serology to analyze immune responses and relate antibody function to clinical outcomes. Its work supports vaccine and therapeutic antibody development, offering services and technologies geared toward understanding how immune responses correlate with treatment effectiveness. Based in Woburn, Massachusetts, the company positions itself globally, collaborating with institutions and organizations to advance research in immunology and related areas. The organization is certified as compliant with GCLP and conducts studies under that standard, underscoring its emphasis on rigorous quality and reliability. In recent developments, SeromYx announced a strategic collaboration with the University of Pittsburgh to advance CAR-T therapy for solid tumors, reflecting its engagement with academic partners to expand applications of its platforms.